Nielsen D - Search Results

1

Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer.

Larsen FO, Jensen BV, Nørgaard HH, Hermann HK, Larsen PN, Markussen A, Hogdall E, Nielsen D. Larsen FO, et al. Among authors: nielsen d. Oncology. 2019;96(6):299-308. doi: 10.1159/000499314. Epub 2019 Apr 18. Oncology. 2019. PMID: 30999314 Clinical Trial.

2

Angiotensin converting enzyme inhibitors for cancer treatment?

Lindberg H, Nielsen D, Jensen BV, Eriksen J, Skovsgaard T. Lindberg H, et al. Among authors: nielsen d. Acta Oncol. 2004;43(2):142-52. doi: 10.1080/02841860310022346. Acta Oncol. 2004. PMID: 15163162 Review.

3

Serum YKL-40, a new prognostic biomarker in cancer patients?

Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Johansen JS, et al. Among authors: nielsen d. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):194-202. doi: 10.1158/1055-9965.EPI-05-0011. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492905 Review.

4

Anthracycline-induced chronic cardiotoxicity and heart failure.

Appel JM, Nielsen D, Zerahn B, Jensen BV, Skagen K. Appel JM, et al. Among authors: nielsen d. Acta Oncol. 2007;46(5):576-80. doi: 10.1080/02841860601156165. Acta Oncol. 2007. PMID: 17562433 Review.

5

Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil.

Pfeiffer P, Nielsen D, Yilmaz M, Iversen A, Vejlø C, Jensen BV. Pfeiffer P, et al. Among authors: nielsen d. Acta Oncol. 2007;46(5):697-701. doi: 10.1080/02841860601009455. Acta Oncol. 2007. PMID: 17562448

6

Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer.

Qvortrup C, Jensen BV, Jorgensen TL, Nielsen D, Bjerregaard JK, Pfeiffer P. Qvortrup C, et al. Among authors: nielsen d. Acta Oncol. 2010 Aug;49(6):833-6. doi: 10.3109/0284186X.2010.482104. Acta Oncol. 2010. PMID: 20615171

7

Bevacizumab in combination with cetuximab and irinotecan after failure of cetuximab and irinotecan in patients with metastatic colorectal cancer.

Larsen FO, Pfeiffer P, Nielsen D, Skougaard K, Qvortrup C, Vistisen K, Fromm AL, Jørgensen TL, Bjerregaard JK, Hoegdall E, Jensen BV. Larsen FO, et al. Among authors: nielsen d. Acta Oncol. 2011 May;50(4):574-7. doi: 10.3109/0284186X.2010.546369. Acta Oncol. 2011. PMID: 21529301

8

Gemcitabine plus docetaxel versus docetaxel in patients with predominantly human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: a randomized, phase III study by the Danish Breast Cancer Cooperative Group.

Nielsen DL, Bjerre KD, Jakobsen EH, Cold S, Stenbygaard L, Sørensen PG, Kamby C, Møller S, Jørgensen CL, Andersson M. Nielsen DL, et al. J Clin Oncol. 2011 Dec 20;29(36):4748-54. doi: 10.1200/JCO.2010.33.9507. Epub 2011 Nov 14. J Clin Oncol. 2011. PMID: 22084374 Clinical Trial.

9

Observer variability in a phase II trial - assessing consistency in RECIST application.

Skougaard K, McCullagh MJ, Nielsen D, Hendel HW, Jensen BV, Johannesen HH. Skougaard K, et al. Among authors: nielsen d. Acta Oncol. 2012 Jul;51(6):774-80. doi: 10.3109/0284186X.2012.667149. Epub 2012 Mar 21. Acta Oncol. 2012. PMID: 22432439 Clinical Trial.

10

Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.

Skougaard K, Nielsen D, Jensen BV, Hendel HW. Skougaard K, et al. Among authors: nielsen d. J Nucl Med. 2013 Jul;54(7):1026-31. doi: 10.2967/jnumed.112.111757. Epub 2013 Apr 9. J Nucl Med. 2013. PMID: 23572497 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,477 results

Search Page